Source: Markets Insider

Cleveland BioLabs: Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger

FORT COLLINS, Colo. and BUFFALO, N.Y., July 6, 2021 /PRNewswire/ -- Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical compan...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more